INSTRUCTIONS Managing sickle cell disease
- To take the test online, go to our secure Web site at http://www.nursingcenter.com/CE/nmie.
- On the print form, record your answers in the test answer section of the CE enrollment form on page 54. Each question has only one correct answer. You may make copies of these forms.
- Complete the registration information and course evaluation. Mail the completed form and registration fee of $21.95 to: Lippincott Williams & Wilkins, CE Group, 2710 Yorktowne Blvd., Brick, NJ 08723. We will mail your certificate in 4 to 6 weeks. For faster service, include a fax number and we will fax your certificate within 2 business days of receiving your enrollment form.
- You will receive your CE certificate of earned contact hours and an answer key to review your results.There is no minimum passing grade.
- Registration deadline is December 31, 2012.
DISCOUNTS and CUSTOMER SERVICE
- Send two or more tests in any nursing journal published by Lippincott Williams & Wilkins together by mail and deduct $0.95 from the price of each test.
- We also offer CE accounts for hospitals and other health care facilities on nursingcenter.com. Call 1-800-787-8985 for details.
Lippincott Williams & Wilkins, publisher of Nursing made Incredibly Easy!, will award 2.3 contact hours for this continuing nursing education activity.
Lippincott Williams & Wilkins is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749 for 2.3 contact hours. Lippincott Williams & Wilkins is also an approved provider of continuing nursing education by the District of Columbia and Florida #FBN2454.
Your certificate is valid in all states.
The ANCC's accreditation status of Lippincott Williams & Wilkins Department of Continuing Education refers only to its continuing nursing educational activities and does not imply Commission on Accreditation approval or endorsement of any commercial product.
Managing sickle cell disease
GENERAL PURPOSE: To provide the professional nurse with an overview of SCD and its symptoms, diagnosis, and treatment.LEARNING OBJECTIVES: After reading this article and taking this test, you'll be able to: 1. Describe the pathophysiology of SCD.2. Identify symptoms of SCD and crisis. 3. Discuss medical and nursing management of SCD.
1. Typically, the two organs that are the most prone to damage from SCD are the
a. kidneys and spleen.
b. heart and liver.
c. lungs and gallbladder.
2. SCD is a result of
a. trauma to the spleen, which interrupts RBC production.
b. inadequate oxygen transport from the lungs into the RBCs.
c. a mutation in the gene responsible for hemoglobin production.
3. Which is the most common type of SCD?
a. hemoglobin SC disease
b. hemoglobin SS disease
c. hemoglobin SB thalassemia disease
4. The average life span of an individual with hemoglobin SS disease is
a. 45 years.
c. 75 years.
5. A person with mostly hemoglobin S with a small percent of normal hemoglobin A has
a. hemoglobin SS disease.
b. hemoglobin SC disease.
c. hemoglobin SB thalassemia disease.
6. The child with sickle cell trait
a. will probably not exhibit symptoms.
b. may convert to full SCD later in life.
c. has two parents with SCD.
7. Which of the following is a trigger for SCD symptoms?
b. folic acid
8. The first symptoms of SCD are usually noticed after the age of
a. 4 to 6 weeks.
b. 4 to 6 months.
c. 5 to 6 years.
9. Anemia and jaundice in SCD are caused by
a. deceased oxygen in tissues.
b. splenic sequestration.
c. RBCs breaking apart.
10. Among the most common causes of death in the young child with SCD are
a. septicemia and meningitis.
b. hand-foot syndrome.
11. Proper management of the patient with SCD should include
a. applying ice to painful extremities.
b. antibiotics for infants to prevent pneumonia.
c. hydroxyurea to reduce pain and inflammation during crisis.
12. Adverse reactions of hydroxyurea include
a. iron toxicity.
b. worsened anemia.
c. increased stickiness of RBCs.
13. Which is currently experimental but has potential as a curative treatment?
a. bone marrow transplant
c. gene therapy
14. Which isn't an indication for blood transfusion?
b. acute pain
c. splenic sequestration
15. Which symptom is least likely to be related to a complication of SCD?
a. swelling of the hands and feet
b. vision changes
c. lower right-sided abdominal pain
16. Which physical activity is best to recommend for an SCD patient?
17. Erythema on the chest of a patient with acute chest syndrome may indicate
a. pulmonary embolus.
b. rib infarction.
18. Which drug is especially helpful in managing the inflammatory pain of SCD crisis?
© 2010 Lippincott Williams & Wilkins, Inc.